1.
Ntertsos N, Christantoniou G, Kyrka K, Pezirkianidou P, Bikos V, Konstantina P, et al. Clinical Approach to Immunotherapy-induced Type 1 Diabetes Mellitus: A Case of Pembrolizumab Associated Insulin-dependent Diabetes in a Patient with NSCLC. J Pulmonol Respir Res [Internet]. 2023 Sep. 25 [cited 2025 Oct. 10];7(2):024-7. Available from: https://www.pulmonolrespirjournal.com/jprr/article/view/jprr-aid1047